Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey MAtt i´m sorry for making advertising on ihub i´m from germany didn´t know this !
Datum: 17.11.06 04:58:28 Uhr
erweiterter Header
Betreff: Lebed.biz Alert - Late night PYPR news just out!!!
Von: Jonathan Lebed <alertlebed@aol.com> ins Adressbuch
17.11.06 04:58
PYPR just announced a 1 billion share buyback plan at 10:34PMEST tonight. I think we are about to see it take off above 1 penny. I still own every single one of my shares. I will promise you right now... the people who sold PYPR today are going to regret it. This stock will not be subpenny for long. This is a no brainer.
nice German chart site
also can read in English
http://home.tiscali.de/chartcheck/
Nice picks Here CKYS alerd!
http://home.tiscali.de/chartcheck/Hotstockland.htm
Yeah when we break 3 cent weeeeeeeeeeeee
New Pick is
PYPR
http://home.tiscali.de/chartcheck/Hotstockland.htm
New pick is
PYPR
http://home.tiscali.de/chartcheck/Hotstockland.htm
it is a Europe side!!
on Chartcheck is a german side
They do togehter with chartcheck a Germanside to brig the Germans to good picks...
But Hotstockland is interantional
http://home.tiscali.de/chartcheck/Hotstockland.htm
FDEI a nice DIVIDENDE player sooon news chance to get in under 10 today
HI!!
GLIF is ROCKING
GLIF is hot on the NEWS yesterday very undervalue now 6 cent this week easy 10 cent
GLIF will break 6 cent soon!
GLIF is moving on very good news yesterday! coould be a 10 bagger
WOW news GLIF what it will fly!
Grant Life Sciences Receives Purchase Order from India for Two Million Point-of-Care (POC), 'Rapid' Malaria Tests to Be Delivered by Year-End
Monday September 11, 11:53 am ET
"This is an important event, because it demonstrates that we are successfully executing our new corporate strategy, part of which is to drive sales through our established marketing channels overseas."
LOS ANGELES--(BUSINESS WIRE)--Sept. 11, 2006--Dr. Hun-Chi Lin, President and Chief Scientist, Grant Life Sciences
Grant Life Sciences Inc. (OTC BB: GLIF - News) announced today that it has received a purchase order from an arm of the Indian government for two million of its point-of-care (POC), 'rapid' malaria tests, to be delivered by year-end. Grant intends to ship approximately 25 percent of the total order immediately. These malaria tests are part of the 'AccuDx' rapid-test product line to which Grant holds exclusive rights from AccuDx Corp.--a biotechnology company founded by Ravi Pottathil, Ph.D., one of the world's leading authorities in the field of HIV/AIDS diagnostics and therapeutics. The AccuDx portfolio includes additional rapid tests for HIV-1, HIV-2, for example, and Dengue Fever.
ADVERTISEMENT
"When we acquired exclusive rights to the AccuDx rapid-test portfolio, we said that we expected to generate revenues from these products in specialty diagnostic markets outside of the United States," said Dr. Hun-Chi Lin, President and Chief Scientist, Grant Life Sciences. "Certainly, this sizable order from India bears strong testimony to the opportunities ahead of us. Indeed, this order demonstrates that we are making considerable progress toward executing our new corporate strategy: (1) to acquire new products and technologies via in-licensing activities; (2) out-license products for further development and sales; and (3) drive sales through our established marketing channels--as is the case with this significant order from India," said Dr. Lin.
About Grant Life Sciences, Inc.
Grant Life Sciences, a development stage company, engages in the research, development, marketing, and sale of diagnostic kits for the screening, monitoring, and diagnosis of diseases with emphasis on women's health, infectious diseases, and cancers.
Forward-Looking Safe Harbor Statement
With the exception of historical information, the matters discussed in this press release are "forward-looking statements" that involve a number of risks and uncertainties. The actual future results of Grant Life Sciences could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates and unanticipated events such as terrorist activities, results of clinical trials, and market acceptance of the Company's products. In some cases, "forward-looking statements" can be identified by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," or other comparable terminology. Although Grant Life Sciences believes that the expectations reflected in the "forward-looking" statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such "forward-looking statements" will be achieved. Grant Life Sciences undertakes no duty to update any of the "forward-looking statements," whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such "forward-looking statements." For further risk factors associated with our Company, review our SEC filings.
Contact:
Grant Life Sciences
Don Rutherford, 949-521-1232
Source: Grant Life Sciences
WOW news GLIF what it will fly!
Grant Life Sciences Receives Purchase Order from India for Two Million Point-of-Care (POC), 'Rapid' Malaria Tests to Be Delivered by Year-End
Monday September 11, 11:53 am ET
"This is an important event, because it demonstrates that we are successfully executing our new corporate strategy, part of which is to drive sales through our established marketing channels overseas."
LOS ANGELES--(BUSINESS WIRE)--Sept. 11, 2006--Dr. Hun-Chi Lin, President and Chief Scientist, Grant Life Sciences
Grant Life Sciences Inc. (OTC BB: GLIF - News) announced today that it has received a purchase order from an arm of the Indian government for two million of its point-of-care (POC), 'rapid' malaria tests, to be delivered by year-end. Grant intends to ship approximately 25 percent of the total order immediately. These malaria tests are part of the 'AccuDx' rapid-test product line to which Grant holds exclusive rights from AccuDx Corp.--a biotechnology company founded by Ravi Pottathil, Ph.D., one of the world's leading authorities in the field of HIV/AIDS diagnostics and therapeutics. The AccuDx portfolio includes additional rapid tests for HIV-1, HIV-2, for example, and Dengue Fever.
ADVERTISEMENT
"When we acquired exclusive rights to the AccuDx rapid-test portfolio, we said that we expected to generate revenues from these products in specialty diagnostic markets outside of the United States," said Dr. Hun-Chi Lin, President and Chief Scientist, Grant Life Sciences. "Certainly, this sizable order from India bears strong testimony to the opportunities ahead of us. Indeed, this order demonstrates that we are making considerable progress toward executing our new corporate strategy: (1) to acquire new products and technologies via in-licensing activities; (2) out-license products for further development and sales; and (3) drive sales through our established marketing channels--as is the case with this significant order from India," said Dr. Lin.
About Grant Life Sciences, Inc.
Grant Life Sciences, a development stage company, engages in the research, development, marketing, and sale of diagnostic kits for the screening, monitoring, and diagnosis of diseases with emphasis on women's health, infectious diseases, and cancers.
Forward-Looking Safe Harbor Statement
With the exception of historical information, the matters discussed in this press release are "forward-looking statements" that involve a number of risks and uncertainties. The actual future results of Grant Life Sciences could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates and unanticipated events such as terrorist activities, results of clinical trials, and market acceptance of the Company's products. In some cases, "forward-looking statements" can be identified by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," or other comparable terminology. Although Grant Life Sciences believes that the expectations reflected in the "forward-looking" statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such "forward-looking statements" will be achieved. Grant Life Sciences undertakes no duty to update any of the "forward-looking statements," whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such "forward-looking statements." For further risk factors associated with our Company, review our SEC filings.
Contact:
Grant Life Sciences
Don Rutherford, 949-521-1232
Source: Grant Life Sciences
FDEI now in good CHANCE go go DIVIDENDE SOON!!
FDEI Buying comes in!! DIVIDENDE soon!!
FDEI will close at 15 cent go go
READ FDEI go go chance to go in DIVIDENDE!
From Yesterdays PR
The cash consideration and number of Maysia shares to be issued will be determined by a valuation of the interests based upon a geological reserve report being prepared. The cash portion will be to satisfy the outstanding secured debt obligations of Silver Star and Fidelis, in order that their interests can be transferred free and clear of all charges and security interests. The balance of the purchase will be paid in Maysia shares, to be issued pro rata to Silver Star and Fidelis proportionate to their interests. The intention is that the Maysia shares will then be paid as a dividend to the Silver Star and Fidelis shareholders. [/B]
READ FDEI go go chance to go in DIVIDENDE!
From Yesterdays PR
The cash consideration and number of Maysia shares to be issued will be determined by a valuation of the interests based upon a geological reserve report being prepared. The cash portion will be to satisfy the outstanding secured debt obligations of Silver Star and Fidelis, in order that their interests can be transferred free and clear of all charges and security interests. The balance of the purchase will be paid in Maysia shares, to be issued pro rata to Silver Star and Fidelis proportionate to their interests. The intention is that the Maysia shares will then be paid as a dividend to the Silver Star and Fidelis shareholders. [/B]
READ FDEI go go chance to go in DIVIDENDE!
From Yesterdays PR
The cash consideration and number of Maysia shares to be issued will be determined by a valuation of the interests based upon a geological reserve report being prepared. The cash portion will be to satisfy the outstanding secured debt obligations of Silver Star and Fidelis, in order that their interests can be transferred free and clear of all charges and security interests. The balance of the purchase will be paid in Maysia shares, to be issued pro rata to Silver Star and Fidelis proportionate to their interests. The intention is that the Maysia shares will then be paid as a dividend to the Silver Star and Fidelis shareholders. [/B]
READ FDEI go go chance to go in DIVIDENDE!
From Yesterdays PR
The cash consideration and number of Maysia shares to be issued will be determined by a valuation of the interests based upon a geological reserve report being prepared. The cash portion will be to satisfy the outstanding secured debt obligations of Silver Star and Fidelis, in order that their interests can be transferred free and clear of all charges and security interests. The balance of the purchase will be paid in Maysia shares, to be issued pro rata to Silver Star and Fidelis proportionate to their interests. The intention is that the Maysia shares will then be paid as a dividend to the Silver Star and Fidelis shareholders. [/B]
FDEI got the DIP this will run again for ne HOD
FDEI now good chance on the DIP close above 20 cent
FDEI on the run READ!!
Chart said 30 cent
Press Release Source: Fidelis Energy Inc.
Fidelis Energy Drills "Archer-Tsakopoulos #1" Well at North Franklin -- To Be Completed as Fourth Gas Well in Reservoir
Wednesday August 16, 9:00 am ET
LOS ANGELES, CA--(MARKET WIRE)--Aug 16, 2006 -- Fidelis Energy, Inc. (OTC BB:FDEI.OB - News) today is pleased to report that the "Archer-Tsakopoulos #1" well was successfully drilled to depth and will now be completed as the fourth gas well at North Franklin, Sacramento, California. A suite of electronic logs confirmed 100% gas filled sand in the producing Winters Formation. Casing was set and the well is to be perforated, completed and tied-in to the pipeline from the Winters sands.
ADVERTISEMENT
The new gas well will add to current production from the Company's three (3) gas wells; the "Archer-Whitney #1," "Archer-Wildlands #1" and "Archer-F1," which totaled 125.713 MMCF in July. The Company anticipates a 25% increase in net monthly gas production from the addition of this well.
The Company is also pleased to report the next gas well, the "Archer-Wurster #1," is expected to spud tomorrow. Fidelis and partners are executing a 2 well drilling program targeting further production at North Franklin.[/B]
Notice Regarding Forward-Looking Statements.
This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the acquisition of oil and gas reserves, (specifically respecting new drilling and production activities at North Franklin) any near-term production or cash flow and our ability to become cash flow positive in the short term to allow us to re-invest production dollars to enhance and grow company assets. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the numerous inherent uncertainties associated with oil and gas exploration. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the 2005 fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
For more information, please visit our website at www.FidelisEnergy.com, or contact:
Investor Relations 1-888-894-3334 (Contact: William Marshall)
ON BEHALF OF THE BOARD
Fidelis Energy Inc.
William Marshall -- President
Contact:
Investor Relations:
1-888-894-3334
Fidelis Energy Inc.
William Marshall
President
Source: Fidelis Energy Inc.
FDEI now at 18 cent and gone!! last chance this is soon a 20 cent pick
WOW FDEI news will come soon
Press Release Source: Fidelis Energy Inc.
Fidelis Energy Drills "Archer-Tsakopoulos #1" Well at North Franklin -- To Be Completed as Fourth Gas Well in Reservoir
Wednesday August 16, 9:00 am ET
LOS ANGELES, CA--(MARKET WIRE)--Aug 16, 2006 -- Fidelis Energy, Inc. (OTC BB:FDEI.OB - News) today is pleased to report that the "Archer-Tsakopoulos #1" well was successfully drilled to depth and will now be completed as the fourth gas well at North Franklin, Sacramento, California. A suite of electronic logs confirmed 100% gas filled sand in the producing Winters Formation. Casing was set and the well is to be perforated, completed and tied-in to the pipeline from the Winters sands.
ADVERTISEMENT
The new gas well will add to current production from the Company's three (3) gas wells; the "Archer-Whitney #1," "Archer-Wildlands #1" and "Archer-F1," which totaled 125.713 MMCF in July. The Company anticipates a 25% increase in net monthly gas production from the addition of this well.
The Company is also pleased to report the next gas well, the "Archer-Wurster #1," is expected to spud tomorrow. Fidelis and partners are executing a 2 well drilling program targeting further production at North Franklin.[/B]
Notice Regarding Forward-Looking Statements.
This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the acquisition of oil and gas reserves, (specifically respecting new drilling and production activities at North Franklin) any near-term production or cash flow and our ability to become cash flow positive in the short term to allow us to re-invest production dollars to enhance and grow company assets. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the numerous inherent uncertainties associated with oil and gas exploration. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the 2005 fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
For more information, please visit our website at www.FidelisEnergy.com, or contact:
Investor Relations 1-888-894-3334 (Contact: William Marshall)
ON BEHALF OF THE BOARD
Fidelis Energy Inc.
William Marshall -- President
Contact:
Investor Relations:
1-888-894-3334
Fidelis Energy Inc.
William Marshall
President
CBCL now good entry chance!
volumeallert XKEM sharpeyed.com
XKEM SOHRT SQEUZZZZZ
CBCL looks good
CBCL nowe enrty chance
CBCL next run!
CBCL will go to 0.03 SOON
CBCL this will explode tomorrow
CBCL ready for the 0.02
When is the meeting with the news Stocks that will come to the market??
EGSR now move and soon ROCK
EGSR news!!!
Energas Resources Inc plans to treat Parkway wells
5/19/2006
May 19, 2006 (M2 EQUITYBITES via COMTEX News Network) --
Energas Resources Inc (OTCBB:EGSR) revealed on 18 May that it plans to treat the first four wells in the Parkway Field.
The treatment of the wells could result in the wells performing at their full potential, according to the company.
Energas Resources said that it plans to use Halliburton engineering to design the frac treatments and perform the workovers, which are likely to generate production from additional zones as well as increase the output from zones currently producing.
Comments on this story may be sent to admin@m2.com
(C)2006 M2 COMMUNICATIONS LTD http://www.m2.com
lokks very good EGSR 50% from here